Truqap is actually a kinase inhibitor that works by blocking pathways that help the most cancers cells endure and grow, so lessens most cancers expansion. Truqap is from a category of medicines identified as an AKT inhibitor. Truqap acquired FDA approval on November 17, 2023, following optimistic outcomes in the https://nathanielo888doa1.liberty-blog.com/profile